N. Shirlene Pearson

872 total citations
5 papers, 126 citations indexed

About

N. Shirlene Pearson is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Ophthalmology. According to data from OpenAlex, N. Shirlene Pearson has authored 5 papers receiving a total of 126 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Radiology, Nuclear Medicine and Imaging, 4 papers in Molecular Biology and 4 papers in Ophthalmology. Recurrent topics in N. Shirlene Pearson's work include Retinopathy of Prematurity Studies (5 papers), Retinal Diseases and Treatments (4 papers) and Retinal Development and Disorders (3 papers). N. Shirlene Pearson is often cited by papers focused on Retinopathy of Prematurity Studies (5 papers), Retinal Diseases and Treatments (4 papers) and Retinal Development and Disorders (3 papers). N. Shirlene Pearson collaborates with scholars based in United States. N. Shirlene Pearson's co-authors include Dianna K. Hughbanks-Wheaton, Rand Spencer, Dennis R. Hoffman, Gary E. Fish, David G. Birch, Martin Klein, Kirsten G. Locke, Yi‐Zhong Wang and Dianna K. Wheaton and has published in prestigious journals such as Investigative Ophthalmology & Visual Science and JAMA Ophthalmology.

In The Last Decade

N. Shirlene Pearson

5 papers receiving 121 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
N. Shirlene Pearson United States	3	104	82	23	18	15	5	126
Sadiq Hassan Nigeria	4	66 0.6×	28 0.3×	33 1.4×	23 1.3×	2 0.1×	11	154
Laura E. Walter United States	2	29 0.3×	118 1.4×	96 4.2×	8 0.4×		2	129
Guenther Rudolph Germany	6	86 0.8×	27 0.3×	4 0.2×	5 0.3×	2 0.1×	17	119
Claudia Priglinger Germany	4	78 0.8×	27 0.3×	7 0.3×	6 0.3×		5	97
Nicola Ungaro Italy	8	67 0.6×	203 2.5×	103 4.5×	1 0.1×	6 0.4×	17	243
Jin Sha United States	4	84 0.8×	18 0.2×	5 0.2×	14 0.8×	2 0.1×	5	111
Carrie Harris Australia	3	112 1.1×	11 0.1×	11 0.5×	2 0.1×	7 0.5×	3	130
Sheila Smiley Canada	3	106 1.0×	18 0.2×	14 0.6×	70 3.9×		3	116
Rose Tan Australia	10	52 0.5×	225 2.7×	177 7.7×	3 0.2×	1 0.1×	18	246
Kalyani Chaubey United States	7	55 0.5×	4 0.0×	3 0.1×	11 0.6×	4 0.3×	8	121

Countries citing papers authored by N. Shirlene Pearson

Since Specialization

Citations

This map shows the geographic impact of N. Shirlene Pearson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Shirlene Pearson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Shirlene Pearson more than expected).

Fields of papers citing papers by N. Shirlene Pearson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Shirlene Pearson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Shirlene Pearson. The network helps show where N. Shirlene Pearson may publish in the future.

Co-authorship network of co-authors of N. Shirlene Pearson

This figure shows the co-authorship network connecting the top 25 collaborators of N. Shirlene Pearson. A scholar is included among the top collaborators of N. Shirlene Pearson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Shirlene Pearson. N. Shirlene Pearson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Hoffman, Dennis R., Dianna K. Wheaton, Rand Spencer, et al.. (2015). Ancillary Outcomes of the DHAX Trial: Docosahexaenoic Acid (DHA) Supplementation in X-Linked Retinitis Pigmentosa (XLRP). Investigative Ophthalmology & Visual Science. 56(7). 3803–3803. 1 indexed citations

2.

Hoffman, Dennis R., Dianna K. Hughbanks-Wheaton, Rand Spencer, et al.. (2015). Docosahexaenoic Acid Slows Visual Field Progression in X-Linked Retinitis Pigmentosa: Ancillary Outcomes of the DHAX Trial. Investigative Ophthalmology & Visual Science. 56(11). 6646–6646. 50 indexed citations

3.

Hughbanks-Wheaton, Dianna K., David G. Birch, Gary E. Fish, et al.. (2014). Safety Assessment of Docosahexaenoic Acid in X-Linked Retinitis Pigmentosa: The 4-Year DHAX Trial. Investigative Ophthalmology & Visual Science. 55(8). 4958–4958. 19 indexed citations

4.

Hoffman, Dennis R., Dianna K. Hughbanks-Wheaton, N. Shirlene Pearson, et al.. (2014). Four-Year Placebo-Controlled Trial of Docosahexaenoic Acid in X-Linked Retinitis Pigmentosa (DHAX Trial). JAMA Ophthalmology. 132(7). 866–866. 54 indexed citations

5.

Wheaton, Dianna K., David G. Birch, Gary E. Fish, et al.. (2002). Safety Assessment of High Dose Docosahexaenoic Acid (DHA) Supplementation in a 4-Year Randomized Clinical Trial in X-linked Retinitis Pigmentosa (XLRP). Investigative Ophthalmology & Visual Science. 43(13). 1391–1391. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact